#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4

  • Study of tulisokibart compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Testing SAR442970 compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    2 1
    Investigated Drugs:
    Belgium Czechia France Germany Poland Spain

  • Study on Fecal Microbiota Transplantation for Crohn’s Disease Patients in Remission After Stopping Anti-TNF Therapy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Using Ultrasound with Perflubutane and Laxative for Detecting Crohn’s Disease in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Study on the Safety of Using Autologous Stromal Vascular Fraction Cells and Micrograft for Treating Hard-to-Heal Ano-Perineal Fistulas in Crohn’s Disease Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark